Evaxion Biotech A/S - ADR

NASDAQ:EVAX   3:59:50 PM EDT
1.89
+0.09 (+5.00%)
Earnings Announcements

Evaxion Biotech Announces Fourth Quarter And Full Year 2021 Financial Results

Published: 03/22/2022 11:35 GMT
Evaxion Biotech A/S - ADR (EVAX) - Evaxion Biotech Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Evaxion Biotech A/s - Cash and Cash Equivalents Expected to Fund Operations for at Least Next 12 Months.
Evaxion Biotech A/s - Qtrly Loss per Share $0.39.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.